Mustang Bio, Inc.

Mustang Bio, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Mustang Bio, Inc. is not a good value stock. Mustang Bio, Inc. is a mediocre stock to choose.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, d...

News

Mustang Bio, Inc. (NASDAQ:MBIO) Short Interest Update

Ticker Report Mustang Bio, Inc. (NASDAQ:MBIO - Get Free Report) was the target of a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 1,620,000...\n more…

Mustang Bio (NASDAQ:MBIO) Trading Up 2.2%

Ticker Report Shares of Mustang Bio, Inc. (NASDAQ:MBIO - Get Free Report) rose 2.2% on Thursday . The company traded as high as $0.40 and last traded at $0.38. Approximately 697,418 shares changed hands during...\n more…

MBIO Stock Earnings: Mustang Bio Beats EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nMBIO stock results show that Mustang Bio beat analyst estimates for earnings per share the second quarter of 2024.\nThe post MBIO Stock...\n more…

Mustang Bio files to sell 6.5M shares by holders

SeekingAlpha.com: All News no summary\n more…

Mustang Bio files to sell 6.5M shares of common stock for holders

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Mustang Bio buys back assets from Chinese company after federal review

Bizjournals.com - Health Care News A Massachusetts biotech chose to reverse course on its plan to sell its manufacturing assets to a Chinese company after a federal government review of the deal.\n more…